Interleukin-15: new kid on the block for antitumor combination therapy.

Van den Bergh, Johan M J; Van Tendeloo, Viggo F I; Smits, Evelien L J M

Van den Bergh, Johan M J; Van Tendeloo, Viggo F I; Smits, Evelien L J M.

Afiliação

Van den Bergh JM; Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.
Van Tendeloo VF; Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.
Smits EL; Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; Center for Oncological Research Antwerp, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: evelien.smits@uza.be.

Cytokine Growth Factor Rev ; 26(1): 15-24, 2015 Feb.

Article em En | MEDLINE | ID: mdl-25306466

Assuntos

Citocinas/uso terapêutico; Neoplasias Hematológicas/terapia; Interleucina-15/uso terapêutico; Neoplasias/terapia; Transferência Adotiva; Animais; Terapia Combinada; Terapia Genética; Meia-Vida; Humanos; Imunoterapia

Palavras-chave

CD8(+) T cells; Combination therapy; Interleukin-15; Natural killer cells; Tumor immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citocinas / Neoplasias Hematológicas / Interleucina-15 / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cytokine Growth Factor Rev Assunto da revista: ALERGIA E IMUNOLOGIA / BIOQUIMICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google